42.58
1.46 (3.55%)
| 前收盘价格 | 41.12 |
| 收盘价格 | 41.91 |
| 成交量 | 515,872 |
| 平均成交量 (3个月) | 1,103,747 |
| 市值 | 1,226,864,128 |
| 市盈率 (P/E TTM) | 9.68 |
| 预期市盈率 (P/E Forward) | 98.04 |
| 价格/销量 (P/S) | 1.37 |
| 股市价格/股市净资产 (P/B) | 1.55 |
| 52周波幅 | |
| 利润日期 | 3 Aug 2026 |
| 营业毛利率 | 7.92% |
| 营业利益率 (TTM) | -0.74% |
| 稀释每股收益 (EPS TTM) | 2.19 |
| 季度收入增长率 (YOY) | 22.70% |
| 季度盈利增长率 (YOY) | 138.60% |
| 总债务/股东权益 (D/E MRQ) | 5.27% |
| 流动比率 (MRQ) | 9.01 |
| 营业现金流 (OCF TTM) | 114.68 M |
| 杠杆自由现金流 (LFCF TTM) | 42.41 M |
| 资产报酬率 (ROA TTM) | 4.40% |
| 股东权益报酬率 (ROE TTM) | 10.86% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 混合的 | 看跌 |
| Medical Devices (全球的) | 混合的 | 看跌 | |
| 股票 | Inspire Medical Systems, Inc. | 看跌 | 看跌 |
AIStockmoo 评分
| 分析师共识 | -2.0 |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -2.0 |
| 平均 | -0.25 |
|
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Small Core |
| 内部持股比例 | 1.11% |
| 机构持股比例 | 119.04% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Deerfield Management Company, L.P. | 31 Mar 2026 | 2,703,238 |
| Soleus Capital Management, L.P. | 31 Mar 2026 | 576,299 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合